×
About 1,425 results

ALLMedicine™ Parainfluenza Virus Center

Research & Reviews  519 results

Severity of SARS-CoV-2 Omicron BA.2 infection in unvaccinated hospitalized children: Co...
https://doi.org/10.1080/22221751.2022.2093135
Emerging Microbes & Infections; Tso WWY, Kwan MYW et. al.

Jun 23rd, 2022 - AbstractThere has been a rapid surge of hospitalization due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variants globally. The severity of Omicron BA.2 in unexposed, unvaccinated, hospitalized children is unknown. W...

Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell
https://clinicaltrials.gov/ct2/show/NCT04710394

Jun 21st, 2022 - Over 200,000 people visit physicians yearly for taste and smell disorders and given the well-documented prevalence of olfactory dysfunction in COVID-19 infection, there is likely to be an increased need to address these concerns. The loss of the s...

Phylogenetic analysis of human parainfluenza type 3 virus strains responsible for the o...
https://doi.org/10.1016/j.jcv.2022.105213
Journal of Clinical Virology : the Official Publication O... Kim HN, Yoon SY et. al.

Jun 21st, 2022 - Human parainfluenza virus 3 (HPIV3) is a major respiratory pathogen that causes acute respiratory infections in infants and children. Since September 2021, an out-of-season HPIV3 rebound has been noted in Korea. The objective of this study was to ...

In Vitro Potential Virucidal Effect Evaluation of Xibornol on Human Adenovirus Type 5, ...
https://doi.org/10.1007/5584_2022_722 10.1055/s-0036-1584803 10.1371/journal.ppat.1010259
Advances in Experimental Medicine and Biology; Verani M, Federigi I et. al.

Jun 15th, 2022 - The availability of virucidal compounds to reduce the impact of respiratory viruses is a relevant topic for public health, especially during the recent coronavirus disease (COVID-19) pandemic. Antimicrobial properties of Xibornol are known since t...

Human parainfluenza 3 and respiratory syncytial viruses detected in pangolins.
https://doi.org/10.1080/22221751.2022.2086071
Emerging Microbes & Infections; Que T, Li J et. al.

Jun 10th, 2022 - Pangolins have gained increasing global attention owing to their public health significance as potential zoonotic hosts since the identification of SARS-CoV-2-related viruses in them. Moreover, these animals could carry other respiratory viruses. ...

see more →

Guidelines  1 results

Community acquired respiratory virus infections in cancer patients-Guideline on diagnos...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125955
European Journal of Cancer (Oxford, England : 1990); von Lilienfeld-Toal M, Berger A et. al.

Sep 30th, 2016 - Community acquired viruses (CRVs) may cause severe disease in cancer patients. Thus, efforts should be made to diagnose CRV rapidly and manage CRV infections accordingly. A panel of 18 clinicians from the Infectious Diseases Working Party of the G...

see more →

Clinicaltrials.gov  26 results

Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell
https://clinicaltrials.gov/ct2/show/NCT04710394

Jun 21st, 2022 - Over 200,000 people visit physicians yearly for taste and smell disorders and given the well-documented prevalence of olfactory dysfunction in COVID-19 infection, there is likely to be an increased need to address these concerns. The loss of the s...

Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein
https://clinicaltrials.gov/ct2/show/NCT03462004

Mar 17th, 2022 - This study will evaluate the safety, infectivity, and immunogenicity of two doses of the HPIV3/ΔHNF/EbovZ GP vaccine candidate when administered intranasally in healthy adults. Participants will be enrolled sequentially in two cohorts. Participant...

Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine, in Healthy Adults, and Children 12 to 59 Months of Age With Serologic ...
https://clinicaltrials.gov/ct2/show/NCT04144348

Jan 6th, 2022 - This clinical study will assess the safety and immunogenicity of 2 dose levels of mRNA-1653, a combined human metapneumovirus and human parainfluenza virus type 3 vaccine, in healthy adults (18 to 49 years of age) and 2 dose levels in children (12...

Exercise and COVID-19 Viral T-cell Immunity
https://clinicaltrials.gov/ct2/show/NCT05019456

Oct 1st, 2021 - Acute upper and lower respiratory tract infections (RTI) due to respiratory viruses, such as, respiratory syncytial virus (RSV), influenza, parainfluenza virus (PIV) and human metapneumovirus (hMPV) are a major public health problem. During the 20...

Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children
https://clinicaltrials.gov/ct2/show/NCT03039621

Aug 27th, 2021 - Study design: international, multicenter double-blind placebo-controlled randomized clinical study in parallel groups. The study will enroll patients of either gender aged from 6 months to 6 years old with clinical manifestations of ARVI within th...

see more →

News  24 results

What is the diagnosis?
https://www.mdedge.com/pediatrics/article/248638/dermatology/what-diagnosis
Jennifer Laborada, Lawrence F. Eichenfield, MD

Nov 12th, 2021 - Numerous morphologies of skin rashes have been described in the setting of COVID-19, including pernio, livedoid rash, exanthem, and vasculitis. This classic constellation of symptoms (palpable purpura on buttocks/legs, abdominal pain, arthralgia,.

Melphalan Triplets Elicit Responses, Are Safe in Relapsed/Refractory Multiple Myeloma
https://www.onclive.com/view/melphalan-triplets-elicit-responses-are-safe-in-relapsed-refractory-multiple-myeloma

Mar 5th, 2021 - The triplet regimen of melphalan flufenamide (Pepaxto; melflufen) with dexamethasone and either daratumumab (Darzalex) or bortezomib (Velcade) demonstrated encouraging clinical activity and was well tolerated in patients with heavily pretreated re...

Metapneumovirus Infections Clinically Indistinguishable From Flu, RSV
https://www.staging.medscape.com/viewarticle/941323

Nov 19th, 2020 - The all-consuming news about SARS-CoV-2 and COVID-19 has overshadowed other viral pathogens that are the cause of severe or fatal lower respiratory infections (LRI) including human metapneumovirus (HMPV). "MPV is really a leading cause of LRI not ...

Metapneumovirus infections clinically indistinguishable from flu, RSV
https://www.mdedge.com/infectiousdisease/article/232013/pulmonary-infections/metapneumovirus-infections-clinically
Neil Osterweil

Nov 17th, 2020 - The all-consuming news about SARS-CoV-2 and COVID-19 has overshadowed other viral pathogens that are the cause of severe or fatal lower respiratory infections (LRI) including human metapneumovirus (HMPV). “MPV is really a leading cause of LRI not.

COVID-19 Characteristics Differ in Children vs Adults
https://www.medscape.com/viewarticle/926805

Mar 13th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Pediatric cases of COVID-19 infection are typically mild, but underlying coinfection may be more common in children than in adults, according to a...

see more →